Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Aetna post-Claritin

This article was originally published in The Tan Sheet

Executive Summary

Aetna's aggressive formulary management steps following OTC switch of Schering-Plough's Claritin have led to 80% decrease in members' use of Rx low- and non-sedating antihistamines, insurer says. After Claritin switched OTC, Aetna moved Schering's Clarinex, Aventis' Allegra, Pfizer's Zyrtec to "non-formulary" status, meaning members of open formulary plan can receive an Rx at the highest tier copay of $30-$35, resulting in no economic incentive for patients to choose Rx products. Aetna also partnered with Wyeth to include Alavert samples in mailings to physicians and members who received an Rx NSA in 2002 (1"The Tan Sheet" Feb. 10, 2002, In Brief). Managed care firm says it is developing a formulary strategy for PPIs following switch of Prilosec (2"The Tan Sheet" June 23, 2003, p. 3)...

You may also be interested in...



Prilosec OTC Approved In 28-, 42-Count Multiple Regimen Sizes

FDA's June 20 approval of Procter & Gamble/ AstraZeneca's Prilosec OTC permits the companies to sell the proton pump inhibitor in packages containing more than one 14-day treatment regimen

Alavert promotions

Wyeth Consumer Healthcare is partnering with Aetna to provide Alavert coupons, information on OTC loratadine to roughly 475,000 of Aetna's commercial members who have received an Rx for any non-sedating antihistamine in the past year, healthcare provider announces Feb. 5. Mailings are slated to begin in February and end in early April, firm says. Wyeth also has engaged in an Alavert marketing program with WellPoint (1"The Tan Sheet" Jan. 6, 2003, In Brief)...

Watch Out Pfizer, Moderna - India’s First mRNA Vaccine Is Here

With India’s first and the world’s third mRNA vaccine, Gennova plans to provide access to its COVID-19 vaccine to those deprived of doses from Pfizer and Moderna. HDT Bio Corp’s suit in the US is not seen impacting marketing plans in India, COO tells Scrip

Topics

Latest News
UsernamePublicRestriction

Register

PS095621

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel